Ibex Ltd SEC Filings

Paul Joseph Inson, Chief People Officer of IBEX Ltd (IBEX), reported a sale of shares to satisfy tax-withholding obligations related to vested restricted stock units. The Form 4 shows a sale of 255 common shares on 08/26/2025 at a price of $29.13 per share. After the sale, the reporting person beneficially owns 7,097 shares in a direct ownership form. The filing states the sale was executed to cover tax withholding and not as a discretionary trade by the reporting person. The form was filed individually and was signed by an attorney-in-fact on 09/15/2025.

IBEX Ltd reporting person Julie K. Casteel sold 295 common shares at $29.13 per share on 08/26/2025 to cover tax withholding on vested restricted stock units. After the sale the reporting person beneficially owned 30,895 shares, held directly. The Form 4 indicates the sales were required to satisfy tax obligations and were not discretionary trades, signaling they were routine administrative transactions related to equity compensation rather than a change in investment view.

IBEX Ltd insider Christina Alice Trofimuk-O'Connor, identified as the company's Chief Legal Officer and a director, reported a sale of 366 common shares on 08/26/2025 at $29.13 per share. After the transaction she beneficially owned 12,571 shares directly. The filing states the sale was executed to satisfy tax withholding obligations arising from the vesting of restricted stock units and was not a discretionary trade. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person. All details above are taken directly from the submitted Form 4.

David Martin Afdahl, Chief Operating Officer of IBEX Ltd (IBEX), reported a non-discretionary sale of 403 common shares on 08/26/2025 at $29.13 per share. The filing states the sale was required to cover tax withholding arising from the vesting of restricted stock units and not a discretionary trade. After the transaction, the reporting person beneficially owned 54,986 common shares directly. The Form 4 was filed as a single-person filing and is signed by an attorney-in-fact.

Bruce Neil Dawson, a director and the company's Chief Sales and CS Officer, reported a sale of 350 common shares of IBEX Ltd on 08/26/2025 at an average price of $29.13 per share. The sale was made to satisfy tax withholding obligations arising from the vesting of restricted stock units and is described as required, not a discretionary trade. After the transaction the reporting person beneficially owned 5,257 shares. The Form 4 was filed as an individual report and signed by an attorney-in-fact.

IBEX Limited reported revenue of $558.3 million for the fiscal year ended June 30, 2025, a 9.8% increase over the prior year, and net income of $36.9 million, up 9.5% from $33.7 million. The company attributed growth to new client wins, expansion in offshore and nearshore capacity, and revenue gains in Retail & E-commerce, HealthTech, Travel, Transportation & Logistics, while FinTech and Telecommunications declined. Fully diluted EPS rose to $2.36 from $1.84, helped by higher net income and fewer diluted shares outstanding.

IBEX operates a global delivery model with 30 centers and approximately 33,000 employees as of June 30, 2025, derives 96% of revenue from U.S. customers, and notes concentration risk with its top three clients representing 26% of revenue and the top client about 11%. Management emphasizes a technology-led strategy built around the Wave iX platform and AI initiatives, while disclosing material risks including client concentration, seasonality, cybersecurity, regulatory and tax considerations, debt covenants, and dependence on third-party telecom and internet channels.

IBEX Ltd director and Chief People Officer Paul Joseph Inson reported a sale of 10,000 common shares on 08/22/2025. The shares were sold in multiple trades at prices ranging from $30.00 to $30.13, with a weighted average sale price reported as $30.0013. After the sale, the reporting person beneficially owned 7,352 shares directly. The filing also indicates the transaction was made pursuant to a prearranged plan intended to satisfy Rule 10b5-1(c), and the filer offers to provide trade-by-trade pricing details upon request.

IBEX Limited reported a proposed sale of 10,000 common shares through RBC Capital Markets with an approximate aggregate market value of $300,013. The filing states the shares represent stock grants acquired on 04/20/2022 from the issuer and that the sale is expected on 08/22/2025 on NASDAQ. The filing shows 13,372,404 shares outstanding, and no other sales by the reporting person in the past three months are reported. The filer also affirms they are not aware of any undisclosed material adverse information and notes the legal warning about intentional misstatements.